{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T18:49:52Z","timestamp":1771872592980,"version":"3.50.1"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,11]]},"abstract":"<jats:sec>\n            <jats:title>OBJECTIVE:<\/jats:title>\n            <jats:p>To evaluate the efficacy of maintenance tocolysis with progestogens compared with placebo or no treatment in women with singleton pregnancies and arrested preterm labor.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>DATA SOURCES:<\/jats:title>\n            <jats:p>Studies without language restrictions were identified from MEDLINE, EMBASE, PubMed, Scopus, the Cochrane Pregnancy and Childbirth Group's Trials Register, the Cochrane Central Register of Controlled Trials, and ClinicalTrials.gov from inception to June 2015. MeSH headings for progestogens were combined with terms regarding labor, tocolysis, or preterm birth. Reference lists of included studies and GoogleSearch were also reviewed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>METHODS OF STUDY SELECTION:<\/jats:title>\n            <jats:p>Randomized controlled trials that compared progestogens as a maintenance treatment after arrested preterm labor in singleton pregnancies with placebo or no treatment were identified. Selected studies evaluated delivery before 37 or 34 weeks of gestation or the latency period from randomization to delivery. Excluded studies used progestogens as prevention in asymptomatic women at risk. Risk of bias assessment, subgroup analysis on type of progestogens used, and sensitivity analysis by high-quality studies were performed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>TABULATION, INTEGRATION, AND RESULTS:<\/jats:title>\n            <jats:p>Sixteen randomized controlled trials consisting of 1,917 participants were included. Study characteristics and quality were recorded. Preterm delivery at less than 37 weeks of gestation was decreased (38.2% compared with 44.3%; relative risk 0.79, 95% confidence interval [CI] 0.65\u20130.97) and pregnancy was prolonged (mean difference 8.1 days; 95% CI 3.8\u201312.4) when women treated with progestogens were compared with placebo or no treatment. There were no differences in the outcome of delivery at less than 34 weeks of gestation (15.6% compared with 18.3%; relative risk 0.77, 95% CI 0.53\u20131.12). However, sensitivity analysis including five high-quality studies showed no significant differences for preterm delivery at less than 37 weeks of gestation (37.2% compared with 36.9%; relative risk 0.91, 95% CI 0.67\u20131.25) or latency period (mean difference 0.6 days; 95% CI \u22123.7 to 4.9).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION:<\/jats:title>\n            <jats:p>There is insufficient high-quality data to inform clinicians and patients about the use of progestogens as maintenance treatment after arrested preterm labor to reduce the incidence of preterm birth or pregnancy prolongation.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/aog.0000000000001676","type":"journal-article","created":{"date-parts":[[2016,10,12]],"date-time":"2016-10-12T12:15:01Z","timestamp":1476274501000},"page":"989-1000","source":"Crossref","is-referenced-by-count":14,"title":["Progestogens as Maintenance Treatment in Arrested Preterm Labor"],"prefix":"10.1097","volume":"128","author":[{"given":"Montse","family":"Palacio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Ronzoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"S\u00e1nchez-Ramos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kellie E.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230711","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1016\/S0140-6736(12)60820-4","article-title":"National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications","volume":"379","author":"Blencowe","year":"2012","journal-title":"Lancet"},{"key":"R2-20230711","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/AOG.0b013e318199924a","article-title":"Tocolytic therapy: a meta-analysis and decision analysis","volume":"113","author":"Haas","year":"2009","journal-title":"Obstet Gynecol"},{"key":"R3-20230711","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1001\/jama.2012.153817","article-title":"Effect of maintenance tocolysis with nifedipine in threatened preterm labor on perinatal outcomes: a randomized controlled trial","volume":"309","author":"Roos","year":"2013","journal-title":"JAMA"},{"key":"R4-20230711","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S0002-9378(99)70582-X","article-title":"Efficacy of maintenance therapy after acute tocolysis: a meta-analysis","volume":"181","author":"Sanchez-Ramos","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"R5-20230711","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/01.AOG.0000150559.59531.b2","article-title":"Progestational agents to prevent preterm birth: a meta-analysis of randomized controlled trials","volume":"105","author":"Sanchez-Ramos","year":"2005","journal-title":"Obstet Gynecol"},{"key":"R6-20230711","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1067\/mob.2003.41","article-title":"Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study","volume":"188","author":"da Fonseca","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"R7-20230711","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1056\/NEJMoa035140","article-title":"Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate","volume":"348","author":"Meis","year":"2003","journal-title":"N Engl J Med"},{"key":"R8-20230711","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1056\/NEJMoa067815","article-title":"Progesterone and the risk of preterm birth among women with a short cervix","volume":"357","author":"Fonseca","year":"2007","journal-title":"N Engl J Med"},{"key":"R9-20230711","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/uog.9017","article-title":"Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial","volume":"38","author":"Hassan","year":"2011","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R10-20230711","doi-asserted-by":"crossref","first-page":"124.e1","DOI":"10.1016\/j.ajog.2011.12.003","article-title":"Vaginal progesterone in women with an asymptomatic sonographic short cervix in the midtrimester decreases preterm delivery and neonatal morbidity: a systematic review and metaanalysis of individual patient data","volume":"206","author":"Romero","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"R11-20230711","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1530\/jrf.0.0520087","article-title":"Demonstration that progesterone \u201cblocks\u201d uterine activity in the ewe in vivo by a direct action on the myometrium","volume":"52","author":"Lye","year":"1978","journal-title":"J Reprod Fertil"},{"key":"R12-20230711","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1067\/mob.2001.116753","article-title":"Reduced binding of progesterone receptor to its nuclear response element after human labor onset","volume":"185","author":"Henderson","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"R13-20230711","doi-asserted-by":"crossref","first-page":"206.e1","DOI":"10.1016\/j.ajog.2011.12.026","article-title":"Prevention of preterm delivery after successful tocolysis in preterm labor by 17 alpha-hydroxyprogesterone caproate: a randomized controlled trial","volume":"206","author":"Rozenberg","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"R14-20230711","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.3109\/14767058.2014.892922","article-title":"The use of 17-hydroxy progesterone in women with arrested preterm labor: a randomized clinical trial","volume":"27","author":"Briery","year":"2014","journal-title":"J Matern Fetal Neonatal Med"},{"key":"R15-20230711","doi-asserted-by":"crossref","first-page":"678","DOI":"10.3109\/01443615.2013.820266","article-title":"Progesterone use after successful treatment of threatened pre-term delivery","volume":"33","author":"Areia","year":"2013","journal-title":"J Obstet Gynaecol"},{"key":"R16-20230711","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ijgo.2014.01.019","article-title":"Maintenance tocolysis with oral micronized progesterone for prevention of preterm birth after arrested preterm labor","volume":"126","author":"Choudhary","year":"2014","journal-title":"Int J Gynaecol Obstet"},{"key":"R17-20230711","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1479-828X.2007.00803.x","article-title":"Progesterone for maintenance tocolytic therapy after threatened preterm labour: a randomised controlled trial","volume":"48","author":"Borna","year":"2008","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"R18-20230711","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1159\/000328719","article-title":"Effect of progesterone as a tocolytic and in maintenance therapy during preterm labor","volume":"72","author":"Arikan","year":"2011","journal-title":"Gynecol Obstet Invest"},{"key":"R19-20230711","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.3109\/14767058.2011.629014","article-title":"Vaginal progesterone after tocolytic therapy in threatened preterm labor","volume":"25","author":"Bomba-Opon","year":"2012","journal-title":"J Matern Fetal Neonatal Med"},{"key":"R20-20230711","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/1471-0528.13061","article-title":"Prevention of preterm delivery with vaginal progesterone in women with preterm labour (4P): randomised double-blind placebo-controlled trial","volume":"122","author":"Martinez de Tejada","year":"2015","journal-title":"BJOG"},{"key":"R21-20230711","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ajog.2015.03.031","article-title":"Vaginal progesterone for maintenance tocolysis: a systematic review and metaanalysis of randomized trials","volume":"213","author":"Suhag","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"R22-20230711","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ajog.2015.01.054","article-title":"17-alpha-hydroxyprogesterone caproate for maintenance tocolysis: a systematic review and metaanalysis of randomized trials","volume":"213","author":"Saccone","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"R24-20230711","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"R25-20230711","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Control Clin Trials"},{"key":"R26-20230711","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"R27-20230711","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2288-5-13","article-title":"Estimating the mean and variance from the median, range, and the size of a sample","volume":"5","author":"Hozo","year":"2005","journal-title":"BMC Med Res Methodol"},{"key":"R28-20230711","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1001\/jama.1990.03440100097014","article-title":"The existence of publication bias and risk factors for its occurrence","volume":"263","author":"Dickersin","year":"1990","journal-title":"JAMA"},{"key":"R29-20230711","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0028-2243(91)90118-5","article-title":"The use of micronized progesterone in the treatment of menace of preterm delivery","volume":"40","author":"Noblot","year":"1991","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R30-20230711","doi-asserted-by":"crossref","first-page":"607906","DOI":"10.5402\/2012\/607906","article-title":"Outcome of vaginal progesterone as a tocolytic agent: randomized clinical trial","volume":"2012","author":"Saleh Gargari","year":"2012","journal-title":"ISRN Obstet Gynecol"},{"key":"R31-20230711","doi-asserted-by":"crossref","first-page":"453.e1","DOI":"10.1016\/j.ajog.2006.09.009","article-title":"Cervical length changes during preterm cervical ripening: effects of 17-alpha-hydroxyprogesterone caproate","volume":"196","author":"Facchinetti","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"R32-20230711","doi-asserted-by":"crossref","first-page":"e7947","DOI":"10.5812\/ircmj.7947","article-title":"The effects of progesterone therapy on the gestation length and reduction of neonatal complications in patients who had received tocolytic therapy for acute phase of preterm labor","volume":"15","author":"Lotfalizadeh","year":"2013","journal-title":"Iran Red Crescent Med J"},{"key":"R33-20230711","first-page":"45","article-title":"Maintenance therapy by vaginal progesterone after threatened idiopathic preterm labor: a randomized placebo-controlled double-blind trial","volume":"4","author":"Sharami","year":"2010","journal-title":"Int J Fertil Steril"},{"key":"R34-20230711","doi-asserted-by":"crossref","first-page":"125","DOI":"10.4172\/2161-0932.1000125","article-title":"Progesterone for prevention of recurrent preterm labor after arrested preterm labor\u2014a randomized controlled trial","volume":"2","author":"Regmi","year":"2012","journal-title":"Gynecol Obstet"},{"key":"R35-20230711","first-page":"99","article-title":"Efficacy of vaginal progesterone for maintenance tocolysis: a recent trend in the management of arrested preterm labour","volume":"77","author":"El-Abidin","year":"2009","journal-title":"Med J Cairo Univ"},{"key":"R36-20230711","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.5455\/2320-1770.ijrcog20141234","article-title":"Role of micronised progesterone in maintenance therapy following arrested preterm labor: a randomised controlled trial","volume":"3","author":"Mishra","year":"2014","journal-title":"Int J Reprod Contracept Obstet Gynecol"},{"key":"R37-20230711","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijgo.2015.06.058","article-title":"A systematic review and meta-analysis of progestogen use for maintenance tocolysis after preterm labor in women with intact membranes","volume":"132","author":"Eke","year":"2016","journal-title":"Int J Gynaecol Obstet"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006250-201611000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T19:28:33Z","timestamp":1689103713000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006250-201611000-00009"}},"subtitle":["A Systematic Review and Meta-analysis"],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000001676","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]}}}